Adare Pharma Solutions is a global, technology-driven CDMO specializing in oral solid dosage forms, offering end-to-end services from product development to commercial manufacturing and packaging. With expertise in small molecule formulations, including tablets, capsules, multiparticulates, and Minitabs, Adare has successfully developed and manufactured over 65 products sold worldwide. Operating seven facilities across the US and Europe, the company ensures seamless integration of global and regional supply chains, delivering secure, flexible, and efficient pathways to market.

Adare’s integrated CDMO services support the entire drug development lifecycle, providing patient-centric solutions that enhance therapeutic performance and address adherence challenges. Its development teams collaborate closely with clients to advance complex formulations, while commercial manufacturing ensures cost-effective production and regulatory compliance. Adare excels in seamless scale-up and tech transfers, involving commercial teams early to optimize capacity, cost, and supply chain security.

With a harmonized quality model, rigorous training, and regular audits, Adare maintains consistent standards across all facilities. Dedicated project managers ensure clear communication and alignment, fostering a customer-centric approach that drives rapid problem-solving and tailored solutions.